4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001209191-21-009455
President and CEO sold 5,112 shares at an average $73.79 ($377,211)
- President and CEO acquired 14,316 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Watts Ryan J. President and CEO | 2021-02-08 | Option exercise | +5,516 | 2,310,165 | I | ||
| Watts Ryan J. President and CEO | 2021-02-08 | Option exercise | +8,800 | 2,318,965 | I | ||
| Watts Ryan J. President and CEO | 2021-02-09 | Sale | −2,667 | $73.24 | $195,328 | 2,316,298 | I |
| Watts Ryan J. President and CEO | 2021-02-09 | Sale | −1,634 | $74.05 | $120,999 | 2,314,664 | I |
| Watts Ryan J. President and CEO | 2021-02-09 | Sale | −811 | $75.07 | $60,883 | 2,313,853 | I |
| Derivatives | |||||||
| Watts Ryan J. President and CEO | 2021-02-08 | Option exercise · Restricted Stock Units | −5,516 | 0 | D | ||
| Watts Ryan J. President and CEO | 2021-02-08 | Option exercise · Restricted Stock Units | −8,800 | 17,600 | D | ||
| Open-market sales · 5,112 sh · avg $73.79 · $377,211 | |||||||
Loading xslF345X03/doc4.xml…